
DRUG vs RWAY
$DRUG vs $RWAY head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DRUG vs RWAY: the quick read
- ·RWAY is the larger company by market cap ($280M vs $276M).
- ·RWAY has been more active on our scanner (12 vs 7 alerts in 30 days).
- ·DRUG has the smaller float (4.5M vs 41.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs UNKNOWN), so they answer to different catalysts and a move in one says little about the other.
- ·RWAY trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 12 and 7 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·RWAY pays a dividend and DRUG does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DRUG and RWAY on TheDesperateTrader.
- Is DRUG or RWAY the better stock?
- "Better" depends on your goal, and these two are not alike. RWAY is the larger company by market cap ($280M vs $276M). RWAY has been more active on our scanner (12 vs 7 alerts in 30 days). DRUG has the smaller float (4.5M vs 41.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DRUG and RWAY?
- The differences that matter: they are not in the same business - DRUG is pharmaceutical preparations and RWAY is unknown; they are similar in size ($276M vs $280M); they trade at very different share prices ($60.98 vs $6.69); DRUG sits at 21% of its 52-week range against 27% for RWAY; only RWAY pays a dividend; our scanner flagged DRUG 7 times in the last 30 days against 12 for RWAY. Everything above is measured from the latest completed session and SEC filings.
- Which of DRUG and RWAY is more active right now?
- Right now DRUG is at about 1.2x its normal volume and RWAY is at about 0.4x, so DRUG is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DRUG or RWAY? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.